Gene: ZSCAN31
Official Full Name: zinc finger and SCAN domain containing 31provided by HGNC
Gene Summary: This gene encodes a protein containing multiple C2H2-type zinc finger motifs. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11868 | ZSCAN31 Knockout cell line (HeLa) | Human | ZSCAN31 | 1:3~1:6 | Negative | Online Inquiry |
KO11869 | ZSCAN31 Knockout cell line (HCT 116) | Human | ZSCAN31 | 1:2~1:4 | Negative | Online Inquiry |
KO11870 | ZSCAN31 Knockout cell line (HEK293) | Human | ZSCAN31 | 1:3~1:6 | Negative | Online Inquiry |
KO11871 | ZSCAN31 Knockout cell line (A549) | Human | ZSCAN31 | 1:3~1:4 | Negative | Online Inquiry |
ZSCAN31 Gene Knockout Cell Lines are engineered cellular models that selectively delete the ZSCAN31 gene, a member of the zinc finger protein family implicated in various biological processes such as cell differentiation, immune response, and cancer development. These knockout cell lines serve as crucial tools for investigating the functional role of ZSCAN31 in gene regulation and cellular pathways, providing researchers with insights into its contributions to both normal physiology and disease states.
The primary mechanism of these cell lines is based on the CRISPR-Cas9 genome editing technology, which enables precise targeting and editing of the genomic sequence. By disrupting the ZSCAN31 coding region, these knockout lines offer the opportunity to study the absence of this gene's activity, allowing scientists to observe subsequent phenotypic changes, alterations in gene expression profiles, and impacts on cellular functionality. This capability positions the ZSCAN31 Gene Knockout Cell Lines as essential for functional genomics studies and therapeutic development.
In research and clinical settings, these cell lines are of significant scientific importance. They provide a platform for drug discovery, particularly in cancer biology, where ZSCAN31 has been linked to tumor progression. Investigators can use these models for screening potential therapeutic candidates aimed at reactivating or inhibiting pathways influenced by ZSCAN31.
Compared to other gene knockout models, ZSCAN31 Cell Lines offer superior specificity and efficiency, minimizing off-target effects often associated with alternative gene manipulation methods. Furthermore, they are available in various cellular backgrounds, providing flexibility for diverse experimental applications.
Researchers, clinicians, and therapeutic developers will find immense value in these knockout cell lines as they allow for the detailed exploration of gene function and the development of novel therapeutic strategies. With our expertise in genomic editing and cell line development, our company is uniquely positioned to offer high-quality ZSCAN31 Gene Knockout Cell Lines, tailored to meet the precise needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.